We are live on ! Find out more
NXGN

NextGen Healthcare, Inc. Common Stock

Delisted

NXGN was delisted on the 8th of November, 2023.

204 hedge funds and large institutions have $869M invested in NextGen Healthcare, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 63 increasing their positions, 88 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 16

4% more funds holding

Funds holding: 197204 (+7)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% more call options, than puts

Call options by funds: $6K | Put options by funds: $6K

14% less capital invested

Capital invested by funds: $1.02B → $869M (-$147M)

28% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 88

Holders
204
Holders Change
+7
Holders Change %
+3.55%
% of All Funds
3.44%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
28
Increased
63
Reduced
88
Closed
16
Calls
$6K
Puts
$6K
Net Calls
Net Calls Change
-$8K
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
176
Tower Research Capital (TRC)
New York
$44K +$28.2K +1,478 +142%
UBS Group
177
UBS Group
Switzerland
$37K -$341K -17,886 -89%
VI
178
Vestcor Inc
New Brunswick, Canada
$28K +$30.2K +1,583 New
CA
179
Clearstead Advisors
Ohio
$26K +$28.6K +1,500 New
Nisa Investment Advisors
180
Nisa Investment Advisors
Missouri
$22K -$32.8K -1,720 -57%
Federated Hermes
181
Federated Hermes
Pennsylvania
$21K -$827K -43,381 -97%
HIIFS
182
Harel Insurance Investments & Financial Services
Israel
$21K -$2.35K -123 -9%
Macquarie Group
183
Macquarie Group
Australia
$20K
VCM
184
Versant Capital Management
Arizona
$16K
Group One Trading
185
Group One Trading
Illinois
$16K +$17.2K +900 New
SWA
186
Sutton Wealth Advisors
Florida
$10.7K
APA
187
American Portfolios Advisors
New York
$8.72K -$12.4K -650 -57%
US Bancorp
188
US Bancorp
Minnesota
$8K -$8.69K -456 -50%
Fifth Third Bancorp
189
Fifth Third Bancorp
Ohio
$8K
TWA
190
TCI Wealth Advisors
Arizona
$7K +$2.96K +155 +62%
IA
191
IFP Advisors
Florida
$3K
PFBT
192
Parkside Financial Bank & Trust
Missouri
$3K
MCM
193
Manchester Capital Management
Vermont
$3K +$3.56K +187 New
HI
194
Harbour Investments
Wisconsin
$3K +$3.81K +200 New
FGAM
195
Financial Gravity Asset Management
Texas
$2.28K -$1.37K -72 -19%
Northwestern Mutual Wealth Management
196
Northwestern Mutual Wealth Management
Wisconsin
$2K
Rockefeller Capital Management
197
Rockefeller Capital Management
New York
$2K +$2.63K +138 New
Simplex Trading
198
Simplex Trading
Illinois
$1K -$4.46K -234 -74%
MAM
199
Meeder Asset Management
Ohio
$1K -$1.18K -62 -65%
LC
200
Lindbrook Capital
California
$1K -$648 -34 -40%

NXGN Hedge Fund Activity: Q2 2022 in Review

204 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in NextGen Healthcare, Inc. Common Stock (NXGN) for Q2 2022, worth a combined $869M — down 14% from $1.02B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new NXGN positions and 16 closed out — a net gain of 12 holders — while 63 added to existing stakes and 88 trimmed.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $9.53M. The largest seller was Point72 Asset Management, cutting an estimated $3.37M.

  • 204 institutional investors held NextGen Healthcare, Inc. Common Stock (NXGN) as of Q2 2022, up from 197 in Q1 2022.
  • Funds reported $869M of NextGen Healthcare, Inc. Common Stock stock for Q2 2022, down 14% quarter-over-quarter.
  • 28 funds opened new NextGen Healthcare, Inc. Common Stock positions in Q2 2022 and 16 closed out, a net change of +12 holders.
  • The largest NextGen Healthcare, Inc. Common Stock buyer in Q2 2022 was Alyeska Investment Group, an estimated $9.53M added.
  • The largest NextGen Healthcare, Inc. Common Stock seller in Q2 2022 was Point72 Asset Management, an estimated $3.37M sold.

Based on aggregated 13F filings for Q2 2022.